Search Results 281-290 of 10615 for Acute lymphadenitis

  1. Using research to guide treatment of recalcitrant chronic rhinosinusitis in patients who are immunocompromised - Mayo Clinic

    Allergic rhinitis. Asthma. Chronic rhinosinusitis with nasal polyps. Nasal septal deviation. Recurrent acute rhinosinusitis. Unilateral ESS history. Hematologic ...

  2. A Study To Evaluate The Onset Of Effect And Time Course Of Change In Lung Function With Benralizumab In Severe, Uncontrolled Asthma Patients With Eosinophilic Inflammation - Mayo Clinic

    A Study To Evaluate The Onset Of Effect And Time Course Of Change In Lung Function With Benralizumab In Severe, Uncontrolled Asthma Patients With Eosinophilic ...

  3. Clinical trials - Oncology (Medical)

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...

  4. Clinical trials - Oncology (Medical)

    ... Acute Lymphoblastic Leukemia (B-ALL) improves outcomes. This trial also studies the outcomes of patients with mixed phenotype acute leukemia (MPAL), and B ...

  5. First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects with Acute Myelogenous Leukemia and Selected B-cell Cancers - Mayo Clinic

    First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects with Acute Myelogenous Leukemia and ...

  6. Hematology - Clinical trials - Mayo Clinic

    ... Acute Lymphoblastic Leukemia (B-ALL) improves outcomes. This trial also studies the outcomes of patients with mixed phenotype acute leukemia (MPAL), and B ...

  7. Systemic mastocytosis - Symptoms and causes - Mayo Clinic

    Sometimes, severe swelling and irritation, called inflammation, results in organ damage. Common triggers include alcohol, insect stings, physical and emotional ...

  8. Rem-422, An MYB MRNA Degrader, In Patients With Relapsed/Refractory AML Or Higher-Risk MDS - Mayo Clinic

    The purpose of this study is to evaluate the safety and tolerability of REM-422 in patients with relapsed/refractory acute myeloid leukemia or higher-risk ...

  9. Clinical trials - Oncology (Medical)

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

  10. Dose Escalation Study Investigating The Safety, Tolerability, Pharmacokinetics, Pharmacodynamics Of ASP2215 In Patients With Relapsed Or Refractory Acute Myeloid Leukemia - Mayo Clinic

    Dose Escalation Study Investigating The Safety, Tolerability, Pharmacokinetics, Pharmacodynamics Of ASP2215 In Patients With Relapsed Or Refractory Acute ...